Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Earnings Results: BHP Group Ltd and Cochlear Ltd
    • News

    Earnings Results: BHP Group Ltd and Cochlear Ltd

    BHP Group Limited – BHP Results for the Year Ended 30 June BHP (ASX: BHP) today reported results for FY20. BHP’s revenues fell by five percent to $42. Billion, while profits fell four percent to $7.9 billion. As a result, BHP will cut the final dividend to 55 US cents, from 78 for FY19. Despite

    Read More
    Public
  • Thedocyard to seek $45m for Ansarada merger to create global SaaS leader
    • News

    Thedocyard to seek $45m for Ansarada merger to create global SaaS leader

    Although having only listed publicly on the ASX six months ago following a $26.5 million IPO, tech company thedocyard (ASX: TDY) is on the move again with a proposed merger with unlisted Ansarada to form a global leader in business services tech.  A proposed merger with Ansarada would require thedocyard to raise an additional $45

    Read More
    Public
  • Veris wins surveying contract for Stockland’s newest residential community
    • News

    Veris wins surveying contract for Stockland’s newest residential community

    Surveying company Veris (ASX: VRS) has strengthened its relationship with property developer Stockland (ASX: SGP) having been awarded a survey and design contract for their newest planned residential community – Katalia Estate. Katalia Estate is expected to take 10 years to complete all 1500 lots, with Veris to provide surveying and planning services for the

    Read More
    Public
  • Diamond amongst the gold – Aurelia Metals the standout amongst gold producers
    • Opinion

    Diamond amongst the gold – Aurelia Metals the standout amongst gold producers

    With gold prices trading at all-time highs, many gold stocks have been pushing higher. In fact, many of them have been rising so hard, and for so long, that they are exceedingly expensive relative to their earnings. However, there exists an Australian base, producing gold miner that is still trading at a reasonable valuation, and

    Read More
    Public
  • Hydrix successfully implants heart attack warning device in four patients
    • News

    Hydrix successfully implants heart attack warning device in four patients

    Since securing the exclusive distribution rights to the AngelMed Guardian device, the only FDA approved implantable heart attack warning system, Hydrix (ASX: HYD) has now successfully implanted the device in four patients in Singapore.  Implanted over a 3-day period, patients were selected based on their previous medical history to ensure they would benefit from the

    Read More
    Public
  • The four ways you can trade Afterpay – Live webinar
    • Opinion

    The four ways you can trade Afterpay – Live webinar

    Over the last few years we’ve seen fintech darling Afterpay Touch (ASX: APT) rise through the ranks of the ASX, making a lot of those who jumped on board plenty of money in a short span of time. It’s no surprise to see it gain so much attention; it has grown at breakneck speeds you’d

    Read More
    Public
  • «
  • ‹
  • 582
  • 583
  • 584
  • 585
  • 586
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.